60 Degrees Pharmaceuticals, Inc. - רווח למניה אחת ב-12 החודשים האחרונים SXTP

סמלים רשמיים של חברת 60 Degrees Pharmaceuticals Inc. (SXTP)

60 Degrees Pharmaceuticals (SXTP) relies on US government defense contracts that ensure a stable cash flow, although the development of antimalarial drugs requires significant R&D expenditures without economies of scale. This chart of EPS YoY TTM in the GURU.Markets terminal illustrates the trend, where 86.00 represents the current level of the metric. Supply and trial efficiency is achieved through extensive outsourcing of international logistics and manufacturing.

60 Degrees Pharmaceuticals, Inc. (SXTP): רווח נקי למניה (EPS TTM) מ-23.11.2025 עד 17.11.2026

60 Degrees Pharmaceuticals Inc. - פילוחים אנליטיים ומדדי מפתח (SXTP)

- מחיר מניה וקונצנזוס הערכת שווי:
- פרטי שווי השוק של המנפיק:
ניתוח ראשוני של החברה:SXTP, 60 Degrees Pharma
מוצרים מיוצרים של 60 Degrees Pharmaceuticals, Inc.

The market views 60 Degrees Pharmaceuticals (SXTP) as a promising asset with high capitalization potential. This indicator measures the annual change in earnings per share over a rolling period, neutralizing seasonal fluctuations and one-off spikes. By analyzing the EPS YoY TTM growth trajectory, an investor can see the actual effectiveness of the company's monetization of its monopoly position in the antimalarial niche. The growth of this metric confirms the business's ability to exercise pricing power over the military and tourism segments. The asset belongs to the high-risk biotechnology company class.